Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

KRX/249420 stock hub

KRX/249420 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

KRX/249420is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

727.8B

Korea Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

KRX/249420

In the news

Latest news · KRX/249420

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E17.8

P25 9.8P50 17.1P75 31.9

Trailing P/E24.7

P25 12P50 23.1P75 39.5

ROE11.5

P25 -17.1P50 0.7P75 8.5

ROIC4

P25 -9P50 1.3P75 6.8

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All KRX/249420 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

218

Groups with data

Currency

KRW

Showing 218 of 218 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	South Korea
Country code	KR
Employees	1,061
Enterprise value	KRW 806.3B
Exchange	Korea Stock Exchange
Financial currency	KRW
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	KR7249420001
Last refreshed	2026-05-10
Market cap	KRW 727.8B
Price	KRW 23,100
Price currency	KRW
Rev Per Employee	534,339,056.07x
Sector	Healthcare
Sic	2834
Symbol	krx/249420
Website	https://www.ildong.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	3.8%
EV Earnings	29.15x
EV/EBIT	45.8x
EV/EBITDA	20.07x
EV/FCF	152.01x
EV/Sales	1.42x
FCF yield	0.73%
Forward P/E	17.75x
P/B ratio	2.97x
P/E ratio	24.66x
P/S ratio	1.28x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	3.06%
EBITDA Margin	7.04%
FCF margin	0.94%
Gross margin	38.73%
Gross Profit	KRW 219.6B
Gross Profit Growth	-5.87%
Gross Profit Growth Q	-5.51%
Gross Profit Growth3 Y	-2.39%
Gross Profit Growth5 Y	-1.61%
Net Income	KRW 27.7B
Net Income Growth Q	-3.45%
Net Income Growth Years	3%
Pretax Margin	5.6%
Profit Margin	4.88%
Profit Per Employee	KRW 26.1M
Profitable Years	1
ROA	1.86
Roa5y	-2.83
ROCE	4.98
ROE	11.51
Roe5y	-32.5
ROIC	3.95
Roic5y	-10.66

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	101.08%
Cagr3y	4.29%
Cagr5y	8.59%
Div CAGR3	-19.33%
Div CAGR5	-12.09%
EPS Growth Q	-15.63
EPS Growth Years	3
FCF Growth	-69.89%
FCF Growth Q	-8.71%
FCF Growth5 Y	1.13%
OCF Growth	-33.02%
OCF Growth Q	-10.79%
OCF Growth5 Y	-0.43%
Revenue Growth	-7.81x
Revenue Growth Q	-5.6x
Revenue Growth Years	0x
Revenue Growth3 Y	-3.85x
Revenue Growth5 Y	0.18x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	KRW 0.98
Assets	KRW 573B
Cash	KRW 65B
Current Assets	KRW 222B
Current Liabilities	KRW 225.1B
Debt	KRW 144.4B
Debt EBITDA	KRW 3.62
Debt Equity	KRW 0.59
Debt FCF	KRW 27.23
Equity	KRW 245.4B
Interest Coverage	1.42
Liabilities	KRW 327.6B
Long Term Assets	KRW 351.1B
Long Term Liabilities	KRW 102.5B
Net Cash	KRW -79.5B
Net Cash By Market Cap	KRW -10.92
Net Debt EBITDA	KRW 1.99
Net Debt Equity	KRW 0.32
Net Debt FCF	KRW 14.98
Tangible Book Value	KRW 223.7B
Tangible Book Value Per Share	KRW 7,101
WACC	9.07

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.99
Inventory Turnover	3.69
Net Working Capital	KRW 52.8B
Quick ratio	0.51
Working Capital	KRW -3.1B
Working Capital Turnover	KRW -45.63

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-10.01%
Dividend Growth	0%
Dividend Growth Years	3%
Dividend per share	KRW 200
Dividend Years	1
Dividend Yield	0.87%
Ex Div Date	2026-03-30
Last Dividend	KRW 200
Payout Ratio	0.22%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	100.98%
200-day SMA	29,230.2
3Y total return	13.43%
50-day SMA	29,590
50-day SMA vs 200-day SMA	50over200
5Y total return	51%
All Time High	79,500
All Time High Change	-70.94%
All Time High Date	2022-04-06
All Time Low	9,280
All Time Low Change	148.92%
All Time Low Date	2020-03-19
ATR	1,291.2
Beta	0.98
Beta1y	0.78
Beta2y	0.78
Ch YTD	-40
High	24,700
High52	45,050
High52 Date	2025-12-12
High52ch	-48.72%
Low	22,800
Low52	11,340
Low52 Date	2025-05-16
Low52ch	103.7%
Ma50ch	-21.93%
Price vs 200-day SMA	-20.97%
RSI	25.43
RSI Monthly	49.79
RSI Weekly	38.24
Sharpe ratio	1.18x
Sortino ratio	2.28
Total Return	-9.14%
Tr YTD	-39.6
Tr1m	-13.16%
Tr1w	-10.98%
Tr3m	-35.05%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	KRW 17.3B
Operating Income Growth	51.54
Operating Income Growth Q	-19.86
Operating Income Growth5 Y	25.66
Operating margin	3.06

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	20,600,566%
Net Borrowing	-33,574,664,490
Shares Insiders	2.11%
Shares Institutions	3.7%
Shares Out	31,508,067
Shares Qo Q	23.11%
Shares Yo Y	10.01%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	KRW 5.1B
Average Volume	204,991.9x
Bv Per Share	7,820.9
CAPEX	KRW -13.6B
Ch1m	-13.16
Ch1w	-10.98
Ch1y	99.65
Ch3m	-35.47
Ch3y	12.68
Ch5y	50
Ch6m	-17.79
Change	-3.14%
Change From Open	-3.75
Close	23,850
Days Gap	0.63
Depreciation Amortization	22,575,872,000
Dollar Volume	12,527,153,100
Earnings Date	2026-05-15
EBIT	KRW 17.3B
EBITDA	KRW 39.9B
EPS	KRW 937
F Score	6
FCF	KRW 5.3B
FCF EV Yield	0.66x
FCF Per Share	KRW 168
Financing CF	-24,088,449,800
Fiscal Year End	December
Founded	1,941
Goodwill	5,527,039,000
Graham Number	12839.1481
Graham Upside	-44.42
Income Tax	KRW 8.1B
Investing CF	-2,279,264,940
Is Primary Listing	1
Last Earnings Date	2026-02-06
Last Report Date	2025-12-31
Last Split Date	2020-03-05
Last Split Type	Forward
Ma150	31,523
Ma150ch	-26.72%
Ma20	27,142.5
Ma20ch	-14.89%
Net CF	-7,421,862,100
Next Earnings Date	2026-05-15
Open	24,000
P FCF Ratio	137.2
P OCF Ratio	38.41
Payment Date	2026-04-24
Position In Range	15.79
Ppne	220,695,543,550
Price Date	2026-05-08
Price EBITDA	KRW 18.24
Ptbv Ratio	3.25
Relative Volume	2.96x
Revenue	566,933,738,490x
SBC By Revenue	0.04x
Share Based Comp	215,079,000
Tax By Revenue	1.42x
Tax Rate	25.37%
Tr6m	-17.25%
Volume	542,301
Z Score	2.38

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

KRX/249420 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+0.9%

$200 annual per share

Payout ratio

+0.2%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

-12.1%

3 consecutive years of growth

Total shareholder yield

-9.1%

Next ex-dividend date: 2026-03-30

Performance

KRX/249420 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns KRX/249420?

Insider, institutional, and short-interest positioning.

Institutional ownership

+3.7%

Share of float held by funds and institutions

Insider ownership

+2.1%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+10.0%

Negative means the company is buying back shares.

Technical

KRX/249420 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

25.4

Below 30: short-term oversold

Price vs 200-day MA

-21.0%

50/200-day relationship not available

Beta (5Y)

0.98

Moves roughly with the market

Sharpe ratio

1.18

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About KRX/249420

Hub-level FAQ points readers to the deeper analysis pages.

What is the current krx/249420 stock rating?

krx/249420 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full krx/249420 analysis?

The full report lives at /stocks/krx/249420/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for krx/249420?

The latest report frames krx/249420 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the krx/249420 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.